Baidu
map

Lancet:基于社区的高血压心血管风险综合干预

2019-09-03 MedSci MedSci原创

研究认为,非内科医生保健工作者(NPHW)、初级保健医生、家庭和提供有效药物的模式可大大改善了血压控制和心血管疾病风险

高血压是全球心血管疾病的主要病因,近日研究人员测试了非内科医生保健工作者(NPHW)、初级保健医生、家庭和提供有效药物的模式对高血压人群心血管疾病风险的影响。

Hope 4在哥伦比亚和马来西亚开展,1371名新发或控制不佳的高血压患者参与,随机分为对照组(n=727)和干预组(n=644)。干预措施包括使用基于平板电脑的简化管理算法和咨询方案,NPHW治疗心血管疾病危险因素;由NPHWs推荐但由医生监督的免费抗高血压药物和他汀类药物以及家庭成员或朋友(治疗支持者)的支持。主要结局为干预组和对照组参与者在12个月时10年Framingham心血管疾病风险评分变化。

97%的参与者完成了12个月的随访(n=1299)。10年心血管疾病风险的Framingham风险评分在对照组为-6.40%,在干预组为-11.17%,差异为-4.78%。干预组收缩压绝对降低11.45 mm Hg,低密度脂蛋白降低0.41 mmol/L。干预组血压得到控制的患者比例为69%(<140 mmHg),对照组为30%。

研究认为,非内科医生保健工作者(NPHW)、初级保健医生、家庭和提供有效药物的模式可大大改善了血压控制和心血管疾病风险。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2032118, encodeId=5805203211899, content=<a href='/topic/show?id=9952e912290' target=_blank style='color:#2F92EE;'>#综合干预#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79122, encryptionId=9952e912290, topicName=综合干预)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Thu Oct 03 06:48:00 CST 2019, time=2019-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082515, encodeId=517e2082515c5, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Wed Mar 04 06:48:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1830235, encodeId=2e1c1830235f9, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun Aug 09 05:48:00 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395841, encodeId=bf051395841cb, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Thu Sep 05 09:48:00 CST 2019, time=2019-09-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2032118, encodeId=5805203211899, content=<a href='/topic/show?id=9952e912290' target=_blank style='color:#2F92EE;'>#综合干预#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79122, encryptionId=9952e912290, topicName=综合干预)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Thu Oct 03 06:48:00 CST 2019, time=2019-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082515, encodeId=517e2082515c5, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Wed Mar 04 06:48:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1830235, encodeId=2e1c1830235f9, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun Aug 09 05:48:00 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395841, encodeId=bf051395841cb, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Thu Sep 05 09:48:00 CST 2019, time=2019-09-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2032118, encodeId=5805203211899, content=<a href='/topic/show?id=9952e912290' target=_blank style='color:#2F92EE;'>#综合干预#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79122, encryptionId=9952e912290, topicName=综合干预)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Thu Oct 03 06:48:00 CST 2019, time=2019-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082515, encodeId=517e2082515c5, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Wed Mar 04 06:48:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1830235, encodeId=2e1c1830235f9, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun Aug 09 05:48:00 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395841, encodeId=bf051395841cb, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Thu Sep 05 09:48:00 CST 2019, time=2019-09-05, status=1, ipAttribution=)]
    2020-08-09 howi
  4. [GetPortalCommentsPageByObjectIdResponse(id=2032118, encodeId=5805203211899, content=<a href='/topic/show?id=9952e912290' target=_blank style='color:#2F92EE;'>#综合干预#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79122, encryptionId=9952e912290, topicName=综合干预)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Thu Oct 03 06:48:00 CST 2019, time=2019-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082515, encodeId=517e2082515c5, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Wed Mar 04 06:48:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1830235, encodeId=2e1c1830235f9, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun Aug 09 05:48:00 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395841, encodeId=bf051395841cb, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Thu Sep 05 09:48:00 CST 2019, time=2019-09-05, status=1, ipAttribution=)]

相关资讯

40岁以后,这5项指标一定要定时筛查丨ASCVD和T2DM新指南

控制血压、血脂、减重依然是降低2型糖尿病与心血管疾病风险的重要措施。

Am J Cardiol: ADAPT-DES研究:高血压合并氯吡格雷抵抗患者远期事件风险高

根据美国心脏病学杂志上发表的ADAPT-DES研究结果,高血压和氯吡格雷血小板反应性高的患者在PCI术后2年发生不良事件风险增加。

又一例高血压引起的肾衰竭,血压不控制,迟早要还的

有一位55岁女士,体检发现尿微量蛋白、血肌酐轻度升高来诊。

一例横纹肌溶解综合征报告,却并非他汀引起!

肌肉疼痛、肌肉无力和酱油色尿,是横纹肌溶解综合征典型的临床三联征。天津中医药大学第一附属医院心内科李彬、刘文豪就遇见这样一位患者,不过不是他汀类药物“惹的祸”。

Eur Heart J:牙周炎与高血压之间的因果关系

由此可见,该研究观察到牙周炎和BP之间的因果关系。

高血压中医诊疗专家共识

高血压已成为全球重大公共卫生问题。为提高中医药防治高血压的临床与科研水平,规范中医药在高血压中的运用,受中华中医药学会心血管病分会委托,以传统中医辨证论治与方证辨证理论为指导,结合现代循证医学理念,通过对历代文献的系统梳理,尤其是近30 年来高血压文献的回顾分析,深入挖掘名老中医经验,先后开展数次专家咨询,对高血压的关键病机、证候特点、经典名方辨证用药规律进行归纳、总结,讨论并制定高血压中医诊疗专

Baidu
map
Baidu
map
Baidu
map